Dr. Yendewa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Medicine-Infectious Diseases & HIV Medicine
Cleveland, OH 44106Phone+1 216-844-8500Fax+1 216-844-1632
Summary
- Dr. George Yendewa is an infectious disease specialist based in Cleveland, OH, with subspecialties in HIV/AIDS Medicine, International Health, Travel & Tropical Medicine, Microbiology, and STD Medicine. He completed his residency in Internal Medicine at One Brooklyn Health System/Brookdale University Hospital and Medical Center, followed by a fellowship in Infectious Disease and a post-doctoral fellowship at Case Western Reserve University/University Hospitals Cleveland Medical Center. He earned his MD from Charles University in Prague Faculty of Medicine and an MPH&TM in Tropical Medicine from Tulane University. Dr. Yendewa has contributed to several publications, including studies on hepatitis B testing, Mpox in people with HIV, SARS-CoV-2 infection differentiation, blood glucose outcomes in HIV patients, and risk stratification of advanced fibrosis in HIV patients.
Education & Training
- University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, 2017 - 2018
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 2015 - 2017
- One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2012 - 2015
- Tulane UniversityMPH&TM, Tropical Medicine, 2010 - 2014
- Charles University in Prague Faculty of MedicineClass of 2008, MD
Certifications & Licensure
- OH State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Impact of Depression and HIV Symptoms on Glycemic Outcomes among Patients with HIV and Type 2 Diabetes: A Clinical Cohort Study.Veronica Joyce Brady, Amanda L Willig, Katerina A Christopoulos, David J Grelotti, George A Yendewa
AIDS and Behavior. 2025-02-17 - Chronic Hepatitis B and COVID-19 Clinical Outcomes in the United States: A Multisite Retrospective Cohort Study.George A Yendewa, Temitope Olasehinde, Frank Mulindwa, Robert A Salata, Amir M Mohareb
Open Forum Infectious Diseases. 2025-02-01 - Prevalence and Correlates of Hepatitis C Viremia Among People With Human Immunodeficiency Virus in the Direct-Acting Antiviral Era.Jimmy Ma, Robin M Nance, Edward Cachay, Stephanie A Ruderman, Mari Kitahata
Open Forum Infectious Diseases. 2025-02-01
Journal Articles
- IgM N-glycosylation correlates with COVID-19 severity and rate of complement depositionHaslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman MC, Krammer F, van Bakel H; IMPACC Network;..., Nature Communications, 1/9/2024
- Ophthalmic Manifestations among HIV Patients at the Main Tertiary Hospital in Freetown, Sierra Leone: A Cross-Sectional StudyMustapha J, Namanga ES, Idriss B, Sesay D, Jiba DF, Russell JBW, Vandy MJ, Deen GF, Yendewa GA, Lakoh S, Venereology, 7/4/2022
Abstracts/Posters
- Characterizing COVID-19 presentation and clinical outcomes in HIV patients in the US.Yendewa GA, Perez JA, Schlick K, Tribout H, McComsey GA, Conference on Retroviruses and Opportunistic Infections (2021) [CROI Abstract 548]., 3/6/2021
- Characterizing first viral failures among antiretroviral therapy initiators in the USDavy-Mendez T, Napravnik S, Wohl DA, Eaton EF, Moore R, Cachay ER, Christopoulos K, Yendewa GA, Mayer KH, Kitahata MM, Eron JJ, for the Centers for AIDS Research Netw..., Conference on Retroviruses and Opportunistic Infections (2021) [CROI Abstract 410]., 3/6/2021
- Second antiretroviral therapy regimen in viremic people with HIV in the US, 2008-2018Davy-Mendez T, Napravnik S, Wohl DA, Eaton EF, Moore R, Cachay ER, Christopoulos K, Yendewa GA, Mayer KH, Kitahata MM, Eron JJ, for the Centers for AIDS Research Netw..., Conference on Retroviruses and Opportunistic Infections (2021) {CROI Abstract 411], 3/6/2021
- Join now to see all
Press Mentions
- IDSA Honors 175 Distinguished Physicians, Scientists with FIDSA DesignationAugust 17th, 2022
- University Hospitals Trial Investigating New Drug That Could Help Patients Recover Faster from Mild Cases of COVID-19March 10th, 2021
- University Hospitals Ready Initiation of BNT162b2 Phase 2/3 COVID-19 Vaccine Trial Next Week: Seeking Minority ParticipationSeptember 11th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
- American Society of Tropical Medicine and HygieneMember
- HIV Medicine AssociationMember
- International AIDS SocietyMember
- International Society for Infectious DiseasesMember
- American Public Health AssociationMember
Other Languages
- Czech
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: